Two doses of BNT162b2 moderately effective for 5- to 11-year-olds
Investigating the protective effects of Dragon’s Blood against radiation
30 June 2022Machine learning model helps identify resistance to key antibiotics for treating tuberculosis
30 June 2022Two doses of BNT162b2 moderately effective for 5- to 11-year-olds
For children aged 5 to 11 years, two doses of BNT162b2 provide moderate protection against documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and symptomatic COVID-19, according to a study published online June 29 in the New England Journal of Medicine.
